| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1421857
[patent_doc_number] => 06515110
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-04
[patent_title] => 'Multivalent antigen-binding proteins'
[patent_app_type] => B1
[patent_app_number] => 09/443213
[patent_app_country] => US
[patent_app_date] => 1999-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 49
[patent_no_of_words] => 21776
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/515/06515110.pdf
[firstpage_image] =>[orig_patent_app_number] => 09443213
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/443213 | Multivalent antigen-binding proteins | Nov 18, 1999 | Issued |
Array
(
[id] => 4379398
[patent_doc_number] => 06277586
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Cloned glutamic acid decarboxylase'
[patent_app_type] => 1
[patent_app_number] => 9/372752
[patent_app_country] => US
[patent_app_date] => 1999-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 10440
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277586.pdf
[firstpage_image] =>[orig_patent_app_number] => 372752
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/372752 | Cloned glutamic acid decarboxylase | Aug 10, 1999 | Issued |
Array
(
[id] => 4338494
[patent_doc_number] => 06284240
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells'
[patent_app_type] => 1
[patent_app_number] => 9/218950
[patent_app_country] => US
[patent_app_date] => 1998-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 60
[patent_no_of_words] => 28155
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284240.pdf
[firstpage_image] =>[orig_patent_app_number] => 218950
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/218950 | Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells | Dec 21, 1998 | Issued |
| 09/212793 | SYNERGISTIC INHIBITION OF HIV-1 FUSION AND ATTACHMENT, COMPOSITIONS AND ANTIBODIES THERETO | Dec 15, 1998 | Abandoned |
Array
(
[id] => 4158926
[patent_doc_number] => 06103889
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Nucleic acid molecules encoding single-chain antigen-binding proteins'
[patent_app_type] => 1
[patent_app_number] => 9/172019
[patent_app_country] => US
[patent_app_date] => 1998-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 49
[patent_no_of_words] => 23020
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103889.pdf
[firstpage_image] =>[orig_patent_app_number] => 172019
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/172019 | Nucleic acid molecules encoding single-chain antigen-binding proteins | Oct 13, 1998 | Issued |
Array
(
[id] => 4136150
[patent_doc_number] => 06121424
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-19
[patent_title] => 'Multivalent antigen-binding proteins'
[patent_app_type] => 1
[patent_app_number] => 9/166094
[patent_app_country] => US
[patent_app_date] => 1998-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 43
[patent_no_of_words] => 23011
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/121/06121424.pdf
[firstpage_image] =>[orig_patent_app_number] => 166094
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/166094 | Multivalent antigen-binding proteins | Oct 4, 1998 | Issued |
Array
(
[id] => 4083591
[patent_doc_number] => 06025165
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Methods for producing multivalent antigen-binding proteins'
[patent_app_type] => 1
[patent_app_number] => 9/166750
[patent_app_country] => US
[patent_app_date] => 1998-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 43
[patent_no_of_words] => 22987
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/025/06025165.pdf
[firstpage_image] =>[orig_patent_app_number] => 166750
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/166750 | Methods for producing multivalent antigen-binding proteins | Oct 4, 1998 | Issued |
Array
(
[id] => 4202641
[patent_doc_number] => 06027725
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-22
[patent_title] => 'Multivalent antigen-binding proteins'
[patent_app_type] => 1
[patent_app_number] => 9/166093
[patent_app_country] => US
[patent_app_date] => 1998-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 43
[patent_no_of_words] => 22530
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/027/06027725.pdf
[firstpage_image] =>[orig_patent_app_number] => 166093
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/166093 | Multivalent antigen-binding proteins | Oct 4, 1998 | Issued |
| 09/149898 | HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS | Sep 7, 1998 | Abandoned |
Array
(
[id] => 1599719
[patent_doc_number] => 06475718
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-11-05
[patent_title] => 'Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus'
[patent_app_type] => B2
[patent_app_number] => 09/149045
[patent_app_country] => US
[patent_app_date] => 1998-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 9
[patent_no_of_words] => 15289
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/475/06475718.pdf
[firstpage_image] =>[orig_patent_app_number] => 09149045
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/149045 | Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus | Sep 7, 1998 | Issued |
Array
(
[id] => 4352811
[patent_doc_number] => 06218181
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-17
[patent_title] => 'Retroviral packaging cell line'
[patent_app_type] => 1
[patent_app_number] => 9/148575
[patent_app_country] => US
[patent_app_date] => 1998-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13455
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/218/06218181.pdf
[firstpage_image] =>[orig_patent_app_number] => 148575
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/148575 | Retroviral packaging cell line | Sep 2, 1998 | Issued |
Array
(
[id] => 4013188
[patent_doc_number] => 05962640
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Methods for preparing novel dipeptide compounds or pharmacuetically acceptable salts thereof'
[patent_app_type] => 1
[patent_app_number] => 9/137608
[patent_app_country] => US
[patent_app_date] => 1998-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15872
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962640.pdf
[firstpage_image] =>[orig_patent_app_number] => 137608
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/137608 | Methods for preparing novel dipeptide compounds or pharmacuetically acceptable salts thereof | Aug 20, 1998 | Issued |
Array
(
[id] => 4023766
[patent_doc_number] => 05993818
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Use of autoantibodies for tumor therapy and prophylaxis'
[patent_app_type] => 1
[patent_app_number] => 9/115214
[patent_app_country] => US
[patent_app_date] => 1998-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6710
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/993/05993818.pdf
[firstpage_image] =>[orig_patent_app_number] => 115214
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/115214 | Use of autoantibodies for tumor therapy and prophylaxis | Jul 13, 1998 | Issued |
Array
(
[id] => 4187624
[patent_doc_number] => 06153431
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-28
[patent_title] => 'Human immunodeficiency virus co-receptor variants associated with resistance to virus infection'
[patent_app_type] => 1
[patent_app_number] => 9/087232
[patent_app_country] => US
[patent_app_date] => 1998-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 12267
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/153/06153431.pdf
[firstpage_image] =>[orig_patent_app_number] => 087232
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/087232 | Human immunodeficiency virus co-receptor variants associated with resistance to virus infection | May 27, 1998 | Issued |
Array
(
[id] => 4375193
[patent_doc_number] => 06303299
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-16
[patent_title] => 'Vitro suppression as a tool for the investigation of translation initiation'
[patent_app_type] => 1
[patent_app_number] => 9/076804
[patent_app_country] => US
[patent_app_date] => 1998-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 9954
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/303/06303299.pdf
[firstpage_image] =>[orig_patent_app_number] => 076804
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/076804 | Vitro suppression as a tool for the investigation of translation initiation | May 12, 1998 | Issued |
Array
(
[id] => 6403360
[patent_doc_number] => 20020037326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'PEPTIDES FOR INHIBITING RETROVIRUSES'
[patent_app_type] => new
[patent_app_number] => 09/054345
[patent_app_country] => US
[patent_app_date] => 1998-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9710
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037326.pdf
[firstpage_image] =>[orig_patent_app_number] => 09054345
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/054345 | PEPTIDES FOR INHIBITING RETROVIRUSES | Apr 1, 1998 | Abandoned |
Array
(
[id] => 3909820
[patent_doc_number] => 06001633
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-14
[patent_title] => 'Cells producing recombinant retrovirus'
[patent_app_type] => 1
[patent_app_number] => 8/952671
[patent_app_country] => US
[patent_app_date] => 1998-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6244
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/001/06001633.pdf
[firstpage_image] =>[orig_patent_app_number] => 952671
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/952671 | Cells producing recombinant retrovirus | Mar 30, 1998 | Issued |
Array
(
[id] => 4153642
[patent_doc_number] => 06114111
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-05
[patent_title] => 'Mammalian protein interaction cloning system'
[patent_app_type] => 1
[patent_app_number] => 9/050863
[patent_app_country] => US
[patent_app_date] => 1998-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8985
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/114/06114111.pdf
[firstpage_image] =>[orig_patent_app_number] => 050863
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/050863 | Mammalian protein interaction cloning system | Mar 29, 1998 | Issued |
| 09/045989 | TREATMENT AND PREVENTION OF HIV INFECTION AND AIDS WITH SARCOID-DERIVED ANTIGENS | Mar 19, 1998 | Abandoned |
| 09/044085 | RETROVIRAL PACKAGING CELL LINE | Mar 17, 1998 | Abandoned |